Small-molecule and CRISPR screening converge to reveal RTK dependencies in pediatric rhabdoid tumors. Oberlick and Rees et al., 2019.

Published: 27 August 2019| Version 1 | DOI: 10.17632/2vcpns9jgw.1
Contributor:
Elaine Oberlick

Description

Raw data underlying several figures from our article in Cell Reports: Oberlick and Rees et al., Small-Molecule and CRISPR Screening Converge to Reveal Receptor Tyrosine Kinase Dependencies in Pediatric Rhabdoid Tumors, Cell Reports (2019), https://doi.org/10.1016/j.celrep.2019.07.021

Files

Categories

Pediatric Cancer, Chromatin Remodeling, Rhabdoid Tumor, Screening, Bioactive Compound, CRISPR

Licence